MSI Negative Colorectal Cancer, MSI Positive Colorectal Cancer research hub

A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations, in Recurrent and Metastatic Microsatellite Instability High (MSI-H) and non-MSI-H Colon Cancer

This study looks at new drug combinations for advanced bowel cancer. It's for people whose cancer has grown or spread, and aims to see how well these new treatments shrink tumours, using drugs that boost the body's own immune system.